These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28506860)

  • 21. Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy.
    Moschini M; Soria F; Abufaraj M; Foerster B; D'Andrea D; Damiano R; Klatte T; Montorsi F; Briganti A; Colombo R; Gallina A; Shariat SF
    Clin Genitourin Cancer; 2017 Aug; 15(4):e681-e688. PubMed ID: 28162943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.
    D'Andrea D; Moschini M; Soria F; Gust KM; Briganti A; Karakiewicz PI; Rouprêt M; Shariat SF
    Anticancer Res; 2017 Oct; 37(10):5747-5753. PubMed ID: 28982896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications.
    Nguyen DP; Al Hussein Al Awamlh B; Faltas BM; O'Malley P; Ayangbesan A; Inoyatov IM; Scherr DS
    Urology; 2015 Jul; 86(1):99-106. PubMed ID: 26142590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Gershman B; Moreira DM; Tollefson MK; Frank I; Cheville JC; Thapa P; Tarrell RF; Thompson RH; Boorjian SA
    Urol Oncol; 2016 Jan; 34(1):4.e1-9. PubMed ID: 26329815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
    Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A
    World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis.
    Xu K; Lang B; Fu B; Shi T; Wang B; Zhang X
    J Endourol; 2017 Dec; 31(12):1259-1268. PubMed ID: 28967303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and outcomes of urethral recurrence following radical cystectomy.
    Boorjian SA; Kim SP; Weight CJ; Cheville JC; Thapa P; Frank I
    Eur Urol; 2011 Dec; 60(6):1266-72. PubMed ID: 21871713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.
    Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
    J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
    Yafi FA; Aprikian AG; Fradet Y; Chin JL; Izawa J; Rendon R; Estey E; Fairey A; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Saad F; Drachenberg D; Kassouf W
    BJU Int; 2012 Nov; 110(9):1317-23. PubMed ID: 22500588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse.
    Zattoni F; Morlacco A; Nehra A; Frank I; Boorjian SA; Thapa P; Karnes RJ
    Int Braz J Urol; 2018; 44(3):491-499. PubMed ID: 29244270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
    Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
    Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
    Kassouf W; Spiess PE; Brown GA; Munsell MF; Grossman HB; Siefker-Radtke A; Dinney CP; Kamat AM
    Eur Urol; 2007 Sep; 52(3):769-74. PubMed ID: 17434254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
    Xylinas E; Rink M; Novara G; Green DA; Clozel T; Fritsche HM; Guillonneau B; Lotan Y; Kassouf W; Tilki D; Babjuk M; Karakiewicz PI; Montorsi F; Abdennabi J; Trinh QD; Svatek RS; Scherr DS; Zerbib M; Shariat SF
    Ann Surg Oncol; 2013 Mar; 20(3):1027-34. PubMed ID: 23099729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada: BJU Int 2012;110(9):1317-23 [Epub 2012 Apr 13].
    Kamat AM
    Urol Oncol; 2013 Jul; 31(5):717-8. PubMed ID: 23796202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Jo JK; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
    Int Urol Nephrol; 2016 Apr; 48(4):489-94. PubMed ID: 26810322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
    Moschini M; Shariat SF; Abufaraj M; Soria F; Klatte T; Croce G; Mattei A; Damiano R; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A
    Urol Oncol; 2017 Apr; 35(4):151.e17-151.e23. PubMed ID: 27932269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.